BRAMPTON, Ont. — Loblaw beat analyst forecasts for the quarter, the Financial Post reports, boosted by strong sales in its pharmacy business at Shoppers Drug Mart, which the retail group acquired this year. Same-store front sales grew 2.5% at Shoppers, while Loblaw saw overall 1.6% growth. Loblaw’s revenue rose 36% to $13.6 billion, a quarter of that coming from Shoppers Drug Mart. The merger saved Loblaw about $44 million in the quarter, but also cost it $46 million in restructuring and reorganization expenses. Net earnings fell to $142 million from $150 million. Adjusted basic net earnings was 90 cents per share, slightly ahead of the average forecast of 87 cents.
Shoppers deal buoys Loblaw results
Most Recent
Most Read
Wayfair to open first bricks-and-mortar store
Tue, May 07th, 2024
AD reports first quarter results
Tue, May 07th, 2024
Tractor Supply makes Q1 gains in comp sales
Tue, May 07th, 2024
Ace milestone, Home Depot’s pro customers in this month’s Dealer News
Tue, May 07th, 2024
Taiga Building Products posts Q1 results
Mon, May 06th, 2024
Ace Hardware in U.S. debuts line of barbecue sauces
Mon, May 06th, 2024
Consumer boycott of Loblaw Companies begins
Fri, May 03rd, 2024
Pont-Masson ad evokes a classic movie
Fri, May 03rd, 2024
Featured Classified: Taiga
Fri, May 03rd, 2024
Canfor announces earnings, acquisition
Thu, May 02nd, 2024